Updated fracture incidence rates for the US version of FRAX.
about
Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study.Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis StudyDefining ethnic and racial differences in osteoporosis and fragility fractures.Clinician's Guide to Prevention and Treatment of OsteoporosisThe incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study.Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures.Comparison of fracture risk prediction among individuals with reduced and normal kidney function.Mortality in the vertebroplasty population.Fracture risk in women with breast cancer: a population-based study.Validation of FRC, a fracture risk assessment tool, in a cohort of older men: the Osteoporotic Fractures in Men (MrOS) Study.Potential Extensions of the US FRAX Algorithm.Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.Novel methods to evaluate fracture risk models.Male osteoporosis: A reviewWHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?Physical Functioning Among Women Aged 80 Years and Older With Previous FractureFracture risk in older, long-term survivors of early-stage breast cancer.Cost-Effectiveness of Osteoporosis Screening Strategies for Men.Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight.Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.Bone and the perimenopause.Trends in fracture incidence: a population-based study over 20 years.Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.Standard radiography: untapped potential in the assessment of osteoporotic fracture risk.Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).Geographic and ethnic disparities in osteoporotic fractures.Immediate versus delayed surgery for hip fractures in the elderly patients: a protocol for a systematic review and meta-analysis.Incidence of hip fracture in Kuwait: a national registry-based study.Unparallel gender-specific changes in the incidence of hip fractures in Tangshan, China.Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989-2008.Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance.Reproducible transient asystolic arrest during intramedullary reaming of the femoral canal: A case report.Secular trends in hip fractures worldwide: opposing trends East versus West.Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.Calculating the Baseline Incidence in Patients Without Risk Factors: A Strategy for Economic Evaluation.Does osteoporosis therapy invalidate FRAX for fracture prediction?Major osteoporotic to hip fracture ratios in canadian men and women with Swedish comparisons: a population-based analysis.Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico.Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
P2860
Q30641539-323FE77E-A639-4DB2-94F7-48F6D9555D20Q33929951-B018EE49-AC3B-4C02-A3A6-3234B97FBCB9Q34172894-6BD5251E-5E3B-4B27-BE07-4657E2CDC40BQ34250632-88C22B49-BE17-4845-95A2-EEDA09682341Q34614085-2D798EE6-5E68-479A-8B4D-17CCA71805CEQ34883881-2E6944ED-0718-460E-B15E-67DD04BDCAD6Q35278384-7DC0889D-7210-4438-8AA4-7A5157A1D81DQ35552387-389F3071-FD36-4B04-828D-4D705945EB49Q35991921-146673B3-0734-42C4-8D0F-2378E5C67049Q36070142-A644E6D1-04A7-4D4A-A2AB-47ECC9B2A7D6Q36184831-DAE984C9-D9B3-466F-A37F-61EE3478AEBEQ36265141-9D85C839-E291-4F3B-A062-D603EBF86FE2Q36529785-25A0647B-427A-41CF-90A9-FB7AC22549E2Q36568540-9EDA002B-EDEB-4893-A71C-2E1D1F2D9465Q36755817-BD40CAA2-CE04-4C46-9E52-DB2659055C4CQ36883821-FDD398AD-B7E0-47B2-AE23-17028EF298F9Q36941189-D0BD1142-86E4-478F-8FB2-65B10E9E5418Q36963672-6EA77E31-923C-4FCB-A912-38326DB846F4Q37085615-7D9F33E2-4B17-41A3-98E4-DE1173902D50Q37156096-FCA49AD5-0A8B-4313-9185-F4D636C97400Q37401883-F0D42F96-25E0-4E6F-801D-A4B40D32A6EDQ37577038-DF923C47-8F38-402C-957C-00F4DA4F699DQ37593831-15DA2720-3933-4B2E-B356-4BE3A2014D6FQ37682546-EC4C051A-7524-45CB-8BFF-84E8E36FEDB7Q38063088-31765C54-458A-4623-A1F8-9FBDA4C90D4CQ38206066-808C9D25-9D04-4B3D-80BC-4987EBBD0F75Q38206067-964DC5E0-2C10-436E-B8EC-2C36017CD695Q38372340-4E0007EA-A9D8-4D5F-9498-5D3E692AB4FCQ38941944-F2E49B24-D4A5-4150-8D29-42DBE8DC66A1Q38965284-18DA792B-E16B-41E7-831E-191EA1863E3EQ39392613-F515DD92-D57A-422A-BD1F-DA92011D9B46Q39872287-812A2136-3471-42C4-8FFF-48E73BF8790FQ40063578-70851AF7-9C9D-439F-98C8-AD5A79A6590CQ40178508-5F2F31E1-08A4-4F03-A74E-9FF5E63CD626Q40208431-53702C91-1A12-4441-92A7-219A77CE6557Q41759950-34FFC0BB-07A1-48CE-8EEE-E0DC076B9D13Q43477917-6364BFA7-2D49-440F-8123-A393C19EABADQ43499727-5D746B1D-9F99-4A02-97AD-4765E3CB3663Q43528980-A1F9591D-70D3-4515-9E22-D0E2D7FD02E7Q44063452-CEAC69BE-F365-4723-A599-FC44326E3A21
P2860
Updated fracture incidence rates for the US version of FRAX.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Updated fracture incidence rates for the US version of FRAX.
@en
Updated fracture incidence rates for the US version of FRAX.
@nl
type
label
Updated fracture incidence rates for the US version of FRAX.
@en
Updated fracture incidence rates for the US version of FRAX.
@nl
prefLabel
Updated fracture incidence rates for the US version of FRAX.
@en
Updated fracture incidence rates for the US version of FRAX.
@nl
P2093
P2860
P1476
Updated fracture incidence rates for the US version of FRAX.
@en
P2093
A R Pressman
B Dawson-Hughes
B Ettinger
L J Melton
P2860
P2888
P356
10.1007/S00198-009-1032-9
P407
P577
2009-08-25T00:00:00Z